One of the things I learned earliest in my career is if you can't hire people that are smarter than you, you will fail. What you gain confidence in with brand marketing over time is that consistency is required. Now, I am so excited for the show today.We have Andrew Dunham, founder and CEO of HIMS. Hims are reinventing healthcare, but wow, it's been a tough 6 months. They are down 66%.They've got a market cap of 4.35% billion as of today, but they do over 2.3% billion in revenue. It's nuts. I'm so excited t ...

High-paying jobs are no longer limited to rigid nine-to-five schedules or offices.Telehealth technology is transforming one of the most lucrative industries in the world and making it easier for patients to receive accessible care, while healthcare professionals enjoy flexible work schedules, a remote work set-up and the ability to earn as much as $300,000+ while doing so.Learn more about the telehealth job market: https://t.co/3M26a836j5 ...

Factory work and office jobs used to be Americans’ most reliable tickets to the middle class. But now, at a time of uncertainty in the labor market, nursing offers not only stability but, for some, a pathway to real prosperity. https://t.co/mTl63e8JOF ...

A surge in diagnoses has created a booming industry, riddled with incentives that drive up costs and distort care https://t.co/3fJQ121WrN ...

The U.S. stock market is experiencing a robust broad-based rally during midday trading this Tuesday, March 31st, 2026. Investors are shaking off recent volatility, evidenced by a significant retreat in the CBOE Volatility Index (VIX), which has plummeted nearly 9.5% to 27.71. This "risk-on" sentiment is being spearheaded by the technology sector, pushing the major indexes toward substantial daily gains as the first quarter of the year draws to a close.Major Market Indexes Show Strong Midday MomentumAs of mi ...

Core Insights - NextPlat Corp reported a consolidated revenue of approximately $54.3 million for the full year 2025, a decrease of 18% compared to approximately $66.1 million in 2024, indicating challenges in revenue generation [3] - The company is focusing on turnaround and cost-cutting initiatives, which are expected to support operational profitability goals in 2026 [2] Financial Performance - The overall gross margin for 2025 declined to approximately 20% from 26% in 2024, with healthcare operations gross margin decreasing to 19% from 26% due to reduced pharmacy 340B contract revenue [4] - Healthcare operations revenue decreased by approximately $12.6 million to $39.7 million in 2025 from $52.3 million in 2024, primarily due to a decline in total prescriptions filled and 340B contract revenue [5] - E-commerce revenues increased slightly to approximately $14.6 million in 2025 from $13.8 million in 2024, driven by higher sales of airtime and hardware [5] Operational Improvements - The company successfully cut over $2 million in annualized costs, streamlined operations, and reduced staff headcount by more than 25% [7] - New high-margin healthcare business development initiatives are being prioritized, including targeting the 340B and long-term care facility markets [7] Future Outlook - NextPlat is positioned for significant growth in 2026, supported by a strong financial foundation and investments in business development and customer service improvements [2] - The company is exploring growth opportunities such as acquisitions and joint ventures to expand its mail order medication fulfillment offerings nationwide [7]

Core Viewpoint - The Schwab U.S. Dividend Equity ETF has undergone its annual reconstitution, increasing its allocation to high-yielding dividend stocks in the healthcare sector, which is expected to enhance long-term income generation for investors [1][3][4]. Group 1: ETF Strategy and Reconstitution - The Schwab U.S. Dividend Equity ETF tracks the Dow Jones U.S. Dividend 100 Index, which selects stocks based on dividend quality characteristics such as yield and financial strength [2]. - In the recent reconstitution, the index removed 22 existing holdings and added 25 new stocks, with significant additions including UnitedHealth at a 4% allocation and Abbott Laboratories at 3.95% [3]. Group 2: Sector Allocation Changes - The ETF's exposure to the healthcare sector increased from 15.4% to 18.9%, making it the second-highest sector allocation after consumer staples [3]. - Notable deletions included AbbVie, which had a previous allocation of 3.31%, although it remains a strong dividend stock [5]. Group 3: Dividend Yield and Growth - Post-reconstitution, the ETF's holdings maintain a similar yield of 3.4%, but the new stocks have a higher average dividend growth rate of 9.4% over the last five years compared to 8.6% prior [4]. - AbbVie has increased its dividend by 5.5% recently and has raised its payout by 330% since its spinoff from Abbott Labs, with a current yield of 3.3% [5].

Core Viewpoint - The disconnect between consumers and their understanding of health insurance policies is a significant issue, and technology like AI can help bridge this gap by simplifying complex documents and highlighting key details that could lead to financial losses [1][3]. Group 1: Consumer Awareness and Technology - Many individuals do not read or comprehend their health insurance policies, leading to potential financial losses [2]. - AI tools, such as chatbots, can provide summaries of insurance contracts and clarify complex terms, helping consumers understand their coverage better [3]. - Failing to utilize available technology may result in overpaying for unnecessary coverage or missing out on entitled benefits [3]. Group 2: Structural Issues in the Insurance System - The insurance system is criticized for creating plans with high deductibles that are unaffordable for most consumers, leading to debt just to access coverage [4]. - Insurers often underpay and delay payments to hospitals, which increases financial strain on healthcare providers and results in additional fees for patients [5]. - The operational inefficiencies within hospital systems, including excessive spending on consultants and a disproportionate number of administrative staff compared to doctors, exacerbate the financial challenges faced by both hospitals and patients [6].

I heard Elon say that if you're a surgeon now, there's just no point. Don't train to be a surgeon. In a couple of years time, Optimus and AI generally are going to be better than any surgeon that's ever lived.Do you think these things are true. >> Well, you know, I I'm pretty sure it was Hinton that famously/ infamously said there will be no need for radiologists anymore. That was 10 years ago, I think, that he said that.He set a deadline that we've already passed. Radiology is doing great as a profession. ...

Core Viewpoint - NextPlat Corp has announced a 1-for-10 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement and to broaden potential investor interest [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split will take effect at 12:01 a.m. Eastern Time on April 6, 2026, with trading on a split-adjusted basis starting on April 7, 2026 [1]. - The number of outstanding shares will decrease from 27,026,215 to approximately 2,702,621 shares, subject to adjustments for fractional shares [1]. - No fractional shares will be issued; any resulting fractional shares will be cashed out [3]. Group 2: Stockholder Impact - The reverse stock split will affect all stockholders uniformly and will not change their percentage ownership interest in the company, except for adjustments related to fractional shares [3]. - The number of shares available under the company's equity incentive plans and the exercise price of outstanding stock options will be proportionately adjusted [3]. Group 3: Company Overview - NextPlat Corp is a global consumer products and services company that provides healthcare and technology solutions through e-commerce and retail channels [5]. - The company aims to assist businesses in optimizing their e-commerce presence and revenue through acquisitions, joint ventures, and collaborations [5].